Strides Pharma Science Limited (BOM:532531)
India · Delayed Price · Currency is INR 997.65
+1.75 (0.18%)
At close: Apr 21, 2026
Strides Pharma Science Employees
Strides Pharma Science had 3,301 employees as of March 31, 2025. The number of employees increased by 236 or 7.70% compared to the previous year.
Employees
3,301
Change (1Y)
236
Growth (1Y)
7.70%
Revenue / Employee
14.32M INR
Profits / Employee
1.55M INR
Market Cap
91.89B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 3,301 | 236 | 7.70% |
| Mar 31, 2024 | 3,065 | 215 | 7.54% |
| Mar 31, 2023 | 2,850 | 203 | 7.67% |
| Mar 31, 2022 | 2,647 | 257 | 10.75% |
| Mar 31, 2021 | 2,390 | -579 | -19.50% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| FDC Limited | 6,857 |
| Jubilant Pharmova | 5,547 |
| CORONA Remedies | 4,500 |
| Granules India | 4,066 |
| Caplin Point Laboratories | 3,966 |
| Gufic Biosciences | 1,484 |
| Procter & Gamble Health | 1,326 |
| Viyash Scientific | 1,244 |
Strides Pharma Science News
- 5 weeks ago - Strides Pharma shares over 3% after acquiring generic brands from Sandoz for US$ 12 million - Business Upturn
- 5 weeks ago - Strides Pharma Science acquires generic brands from Sandoz for US$ 12 million - Business Upturn
- 2 months ago - Strides Pharma Science Ltd (BOM:532531) Q3 2026 Earnings Call Highlights: Record EBITDA and ... - GuruFocus
- 2 months ago - Q3 2026 Strides Pharma Science Ltd Earnings Call Transcript - GuruFocus
- 2 months ago - Strides Pharma Science shares jump over 4% after Q3 profit surges 130% YoY to Rs 202 crore - Business Upturn
- 2 months ago - Strides Pharma Q3 Results: Net profit surges 130% YoY to Rs 202 crore, revenue up 3.6% - Business Upturn
- 6 months ago - Strides Pharma Science Ltd (BOM:532531) Q2 2026 Earnings Call Highlights: Strong Revenue Growth ... - GuruFocus
- 6 months ago - Q2 2026 Strides Pharma Science Ltd Earnings Call Transcript - GuruFocus